Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
amy.boyd@paediatrics.ox.ac.uk

Amy Boyd

Recent publications

A systematic review and bayesian meta-analysis of medical devices used in chronic pain management.

Shetty A. et al, (2024), Sci Rep, 14

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.

Hamaluba M. et al, (2023), Wellcome open research, 8, 182 - 182

Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trial.

Jenkin D. et al, (2023), Lancet Infect Dis, 23, 956 - 964

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.

Hamaluba M. et al, (2023), Wellcome Open Res, 8

Adaptation and Cryptic Pseudogenization in Penguin Toll-Like Receptors.

Fiddaman SR. et al, (2022), Mol Biol Evol, 39

More publications